1. Home
  2. MRKR vs CARV Comparison

MRKR vs CARV Comparison

Compare MRKR & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • CARV
  • Stock Information
  • Founded
  • MRKR N/A
  • CARV 1948
  • Country
  • MRKR United States
  • CARV United States
  • Employees
  • MRKR N/A
  • CARV N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • MRKR Health Care
  • CARV Finance
  • Exchange
  • MRKR Nasdaq
  • CARV Nasdaq
  • Market Cap
  • MRKR 11.6M
  • CARV 13.2M
  • IPO Year
  • MRKR N/A
  • CARV 1994
  • Fundamental
  • Price
  • MRKR $0.96
  • CARV $2.38
  • Analyst Decision
  • MRKR Strong Buy
  • CARV
  • Analyst Count
  • MRKR 3
  • CARV 0
  • Target Price
  • MRKR $13.17
  • CARV N/A
  • AVG Volume (30 Days)
  • MRKR 2.7M
  • CARV 254.4K
  • Earning Date
  • MRKR 11-13-2025
  • CARV 11-13-2025
  • Dividend Yield
  • MRKR N/A
  • CARV N/A
  • EPS Growth
  • MRKR N/A
  • CARV N/A
  • EPS
  • MRKR N/A
  • CARV N/A
  • Revenue
  • MRKR $5,388,071.00
  • CARV $22,032,000.00
  • Revenue This Year
  • MRKR N/A
  • CARV N/A
  • Revenue Next Year
  • MRKR $15.82
  • CARV N/A
  • P/E Ratio
  • MRKR N/A
  • CARV N/A
  • Revenue Growth
  • MRKR 44.55
  • CARV N/A
  • 52 Week Low
  • MRKR $0.81
  • CARV $1.30
  • 52 Week High
  • MRKR $5.95
  • CARV $3.85
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 41.99
  • CARV 52.51
  • Support Level
  • MRKR $0.91
  • CARV N/A
  • Resistance Level
  • MRKR $1.02
  • CARV $3.85
  • Average True Range (ATR)
  • MRKR 0.06
  • CARV 0.40
  • MACD
  • MRKR 0.02
  • CARV -0.09
  • Stochastic Oscillator
  • MRKR 72.00
  • CARV 61.56

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: